Filing Details

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.         )*

 

 

NextGen Healthcare, Inc.

(Name of Issuer)

 

 

Common Stock

(Title of Class of Securities)

65343C102

(CUSIP Number)

Mary Ann Frantz, Miller Nash Graham & Dunn LLP

111 S.W. Fifth Avenue, Suite 3400, Portland, Oregon 97204

(503)-224-5858

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

September 12, 2019

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☐

Rule 13d-1(b)

 

☒

Rule 13d-1(c)

 

☐

Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

SCHEDULE 13G

 

CUSIP No. 6534C102

 

1		Names of Reporting Persons I.R.S. Identification Nos. of Above Persons (Entities Only)   Ahmed D. Hussein
2		Check the appropriate box if a member of a Group (see instructions)   (a)  ☐ (b)  ☐
3		SEC Use Only
4		Citizenship or Place of Organization   United States of America and Egypt
Number of Shares Beneficially Owned by Each Reporting Person With:				5		Sole Voting Power   4,884,918
				6		Shared Voting Power   0
				7		Sole Dispositive Power   4,884,918
				8		Shared Dispositive Power   0
9		Aggregate Amount Beneficially Owned by Each Reporting Person   4,884,918
10		Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)   ☐
11		Percent of class represented by amount in row (9)   7.5%
12		Type of Reporting Person (See Instructions)   IN

 

Page 2 of 4

Item 1.

 

(a)	Name of Issuer: NextGen Healthcare, Inc.

 

(b)	Address of Issuers Principal Executive Offices:

 

18111 Von Karman Ave., Suite 800

Irvine, California 92612

Item 2.

 

(a)	Name of Person Filing: Ahmed D. Hussein

 

(b)	Address of Principal Business Office or, if None, Residence:

 

630 Fifth Avenue, Suite 2258

New York, New York 10111-0100

 

(c)	Citizenship: United States and Egypt

 

(d)	Title and Class of Securities: Common Stock

 

(e)	CUSIP No.: 65343C102

 

Item 3.

N/A

 

Item 4.

Ownership

 

(a)	Amount Beneficially Owned: 4,884,918

 

(b)	Percent of Class: 8.3%

 

(c)	Number of shares as to which such person has:

 

(i)

Sole power to vote or to direct the vote: 4,884,918

 

(ii)

Shared power to vote or to direct the vote: 0

 

(iii)

Sole power to dispose or to direct the disposition of: 4,884,918

 

(iv)

Shared power to dispose or to direct the disposition of: 0

 

Item 5.

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [    ].

 

Item 6.

Ownership of more than Five Percent on Behalf of Another Person. N/A

 

Item 7.

Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. N/A

 

Page 3 of 4

Item 8.

Identification and classification of members of the group. N/A

 

Item 9.

Notice of Dissolution of Group. N/A

 

Item 10.

Certifications.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

Page 4 of 4